Table 1.
Advance | Example(s) |
---|---|
Gene therapy | infant ataxias, including SMA |
Drug re-purposing | tPA for ischemic stroke; thalidomide in neuro-oncology; ketamine in major depressive disorder |
Biochemical markers for detection of brain pathologies in living humans | p-Tau217, etc. in AD. NF-L in AD and related dementias |
Therapeutic antibodies and other immune modulators | Tysabri™ for MS Aducanumab, Lecanumab, Donanemab for AD |
Abbreviations: AD: Alzheimer disease; MS: multiple sclerosis; SMA: spinal muscular atrophy.